📖 Approx. 3 minutes ／ Updated: 2026.06.23
In this article, a medical industry M&A advisor will explain from a practical perspective what issues corporate demergers present in business succession and medical M&A involving patient continuity of care. We will provide specific countermeasures based on the continuity of regular patients, timing of notification, and the restrictions and utilization under the Medical Care Act.
1. Industry Background of Corporate Demergers and Patient Continuity of Care
According to the Ministry of Health, Labour and Welfare’s Survey of Medical Institutions, the business environment for medical institutions, including those providing patient continuity of care, has become increasingly severe in recent years due to complex factors such as revisions to medical fees, rising personnel costs, and the burden of capital investment. Particularly from the perspective of maintaining regular patients and the timing of notification, interest in third-party succession M&A is growing.
At the same time, corporate demergers are an important issue in medical M&A practice. By appropriately designing the restrictions and utilization under the Medical Care Act, a succession beneficial to both the transferor and transferee can be achieved.
2. Key Practical Points
- Preparation: Organize the business flow, patient base, and equipment status specific to patient continuity of care, and clarify the transfer conditions.
- Business Valuation: Calculate an appropriate transfer price range based on the characteristics of the medical specialty. In patient continuity of care, the continuity of regular patients and the timing of notification are key to valuation.
- Corporate Demerger Design: Select the optimal scheme based on the restrictions and utilization under the Medical Care Act. Verification from tax, legal, and labor perspectives is also necessary.
- Partner Search & Matching: Select potential transferees suitable for the medical specialty from a nationwide network. Carefully coordinate desired conditions.
- Due Diligence: Conduct a thorough investigation from financial, legal, labor, and medical practice perspectives. Also confirm licenses, permits, and facility standards specific to patient continuity of care.
- Final Agreement & Closing: Conclude the final agreement, including representations and warranties and indemnity clauses. Proceed with license/permit transfer and staff notification in parallel.
3. Specific Considerations for Patient Continuity of Care
In M&A of medical institutions involving patient continuity of care, the continuity of regular patients and the timing of notification hold the key to successful succession. Numerous individual issues exist depending on the medical specialty, such as the continuity of the patient base, maintaining employment of staff (doctors, nurses, allied health professionals), equipment status and renewal plans, and maintaining/acquiring facility standards.
Furthermore, strategic design based on market characteristics unique to patient continuity of care, such as the composition of insured and self-pay medical services, the status of regional medical collaboration, and relationships with nearby competing medical institutions, is crucial. Leveraging our track record in supporting patient continuity of care succession, we provide practical support from an industry-specific perspective.
4. Practical Details of Corporate Demergers
Corporate demergers are an area requiring specialized consideration in medical M&A. Design based on the restrictions and utilization under the Medical Care Act is key to success.
- Confirmation of Relevant Laws and Practical Standards: Preparation based on the Medical Care Act, tax laws, and labor laws.
- Collaboration with Experts: Cooperation with certified public accountants, tax accountants, lawyers, and labor and social security attorneys.
- Risk Assessment: Identification of potential risks and formulation of countermeasures.
- Consensus Building Between Parties: Designing mutually agreeable conditions for both the transferor and transferee.
- Proper Documentation: Clear specification in the basic agreement and final contract.
Frequently Asked Questions
Q. What documents are required for a consultation?
A. It would be helpful if you could prepare financial statements for the past three fiscal years, patient number trends, staff composition, equipment list, and lease agreements (if applicable) in advance. We will receive them after an NDA is signed.
Q. What is the market price range for patient continuity of care transfers?
A. For patient continuity of care, the continuity of regular patients and the timing of notification are key valuation factors. As a guideline, for clinics without beds, it’s 0.5 to 1.5 times annual revenue, and for hospitals with beds, it’s 3 to 7 times EBITDA. We will provide more details in a free preliminary assessment.
Q. What are the precautions when proceeding with a corporate demerger?
A. Prior design based on the restrictions and utilization under the Medical Care Act is essential. Seamless execution of practical matters through expert collaboration is key to success.
Q. Will staff or patients find out about the consultation?
A. Information will be disclosed on a limited basis after an NDA is signed, and no disclosure to related parties will occur before the final agreement. We ensure strict confidentiality.
Related Columns
- Complete Guide to Hospital and Medical Corporation Business Succession | Medical M&A Practices from Successor Shortages to Success Stories
- Complete Guide to Clinic Sales and Transfers | Medical M&A Experts Explain Price Ranges, Procedures, and Precautions
- How to Proceed with Medical M&A and Hospital Succession | Explaining 6 Steps from Consultation to Agreement with Case Studies
- Complete Guide to Tax Schemes for Medical Corporation M&A | Key Issues for Tax Accountants and CPAs
For consultations on Corporate Demergers and Patient Continuity of Care, contact M&A Medical.
Strict Confidentiality, Free Initial Consultation, Success-Based Fee